We previously showed that Chlamydia trachomatis (CT)-specific systemic CD4+ IFN-γ production is an immune correlate of protection against chlamydia reinfection [5], which is consistent with murine chlamydia model findings [6]. This evidence concerns the gene CD4 and chlamydia trachomatis infectious disease.